Acinon


Indications and Reactions:

Role Indications Reactions
Secondary
Rheumatoid Arthritis 15.2%
Hypertension 14.6%
Anxiety 7.6%
Drug Use For Unknown Indication 7.6%
Gastritis 7.6%
Cardiac Failure 6.3%
Parkinsonism 5.7%
Product Used For Unknown Indication 5.1%
Crohn's Disease 3.8%
Neurogenic Bladder 3.8%
Spinal Ligament Ossification 3.2%
Arthritis 2.5%
Constipation 2.5%
Cystitis 2.5%
Prophylaxis Against Gastrointestinal Ulcer 2.5%
Delusion 1.9%
Dementia 1.9%
Diabetes Mellitus 1.9%
Liver Disorder 1.9%
Nephrotic Syndrome 1.9%
Nephrotic Syndrome 13.6%
Supraventricular Extrasystoles 13.6%
Hypoglycaemia 9.1%
Platelet Count Decreased 9.1%
Toxic Epidermal Necrolysis 9.1%
Urinary Tract Infection 9.1%
Withdrawal Syndrome 9.1%
Blood Triglycerides Increased 4.5%
Epistaxis 4.5%
Interstitial Lung Disease 4.5%
Loss Of Consciousness 4.5%
Tremor 4.5%
Uterine Haemorrhage 4.5%
Concomitant
Rheumatoid Arthritis 16.4%
Hypertension 11.3%
Prophylaxis 10.3%
Product Used For Unknown Indication 8.9%
Chronic Hepatitis C 7.7%
Drug Use For Unknown Indication 7.6%
Gastritis 4.9%
Osteoporosis 4.9%
Constipation 4.4%
Hepatitis C 3.9%
Insomnia 3.0%
Diabetes Mellitus 2.3%
Crohn's Disease 2.2%
Cancer Pain 2.0%
Gastric Ulcer 1.9%
Angina Pectoris 1.8%
Hyperlipidaemia 1.8%
Depression 1.7%
Type 2 Diabetes Mellitus 1.6%
Asthma 1.5%
Vomiting 10.3%
Pyrexia 6.7%
White Blood Cell Count Increased 6.7%
Pneumonia 6.1%
White Blood Cell Count Decreased 6.1%
Nausea 5.5%
Tremor 5.5%
Interstitial Lung Disease 4.8%
Pneumocystis Jiroveci Pneumonia 4.8%
Rash 4.8%
Renal Impairment 4.8%
Thrombotic Stroke 4.8%
Delirium 4.2%
Productive Cough 4.2%
X-ray Abnormal 4.2%
Hyperglycaemia 3.6%
Platelet Count Decreased 3.6%
Aspartate Aminotransferase Increased 3.0%
Liver Disorder 3.0%
Nephrotic Syndrome 3.0%

Drug Data